Cargando…
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
BACKGROUND: Diabetic nephropathy (DN) is a serious vascular complication of diabetes and an important cause of end-stage renal disease. One mechanism by which hyperglycemia causes nephropathy is through the formation of advanced glycation end products (AGE). Development of vaccination would be a pro...
Autores principales: | Mashitah, Musthika Wida, Azizah, Nurona, Samsu, Nur, Indra, Muhammad Rasjad, Bilal, Muhammad, Yunisa, Meti Verdian, Arisanti, Amildya Dwi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531026/ https://www.ncbi.nlm.nih.gov/pubmed/26346342 http://dx.doi.org/10.2147/DMSO.S86332 |
Ejemplares similares
-
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
por: Samsu, Nur
Publicado: (2021) -
Amadori albumin in diabetic nephropathy
por: Neelofar, Km., et al.
Publicado: (2015) -
Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
por: Samsu, Nur, et al.
Publicado: (2019) -
Serum Albumin Modifies the Effect of Peripheral Blood Monocytes on Severity of Diabetic Nephropathy
por: Cristancho, Cagney
Publicado: (2021) -
Evaluation of the Relationship Between Microalbuminuria and Urine Ischemia‐Modified Albumin Levels in Patients with Diabetic Nephropathy
por: Bilgi, Mustafa, et al.
Publicado: (2016)